Andrew Ronchi - Chief Executive Officer, dorsaVi Ltd.
Current Role and Company
Andrew James Ronchi is the Chief Executive Officer and Executive Director of dorsaVi Ltd., a company founded in 2008 that specializes in motion analysis technologies. As the CEO, he oversees all aspects of the company's operations, including its development and sale of innovative wearable sensor technologies.
Professional Background
Prior to co-founding dorsaVi, Dr. Ronchi was a practising physiotherapist, working both in an AFL club and in private practice. He was a founding partner in two physiotherapy centers, with the largest employing 28 staff members, including 13 physiotherapists.
Education
Dr. Ronchi completed a PhD in Computer and Systems Engineering, focusing on the reliability and validity of transducers for measuring lumbar spine movement. His academic background and professional experience have been pivotal in the development of dorsaVi's cutting-edge technologies.
dorsaVi Ltd. Overview
dorsaVi Ltd. is recognized for developing and marketing a range of motion analysis solutions internationally, including:
- ViMove+: A clinical and sports solution.
- ViSafe: Wearable sensor technology for workforce movement analysis and injury risk reduction.
- myViSafe: Used for identifying and mitigating injury risks in workplaces.
- ViPerform: Offers objective data to guide athletic training and recovery programs.
The company also offers telehealth solutions and professional suites, with operations based in Oakleigh South, Australia.
Notable Achievements and Activities
- Under Dr. Ronchi's leadership, dorsaVi has introduced technologies that combine video with sensor data to optimize performance and reduce injuries, particularly in sports and clinical settings.
- Dr. Ronchi is actively involved in presenting the company's capabilities and innovations, as demonstrated by his discussion of ViMove+ running metrics.
Leadership Team
The leadership team at dorsaVi includes:
- Dan Ronchi: Chief Technology Officer
- Michael Panaccio: Acting Chairman, Non-Executive Director
- David Erikson: Chief Technology Officer
- Zoe Whyatt: Chief Operating Officer - Dorsavi Europe
- John Kowalczyk: President of Dorsavi US
Company Performance Metrics
- Revenue: In 2023, dorsaVi Ltd. reported a revenue of AUD $2.1 million.
- Shareholder Return: DorsaVi’s total shareholder return as of June 28, 2024, resulted in a 0% change over the past year, reflecting varying market performance.
Recent Public Engagement
- Andrew Ronchi has been active on LinkedIn, sharing insights and engaging with both the medical and broader professional community. Notable posts include empowering athletes with innovative technologies and addressing issues in women's football.
Conclusion
Andrew Ronchi's extensive background in physiotherapy and engineering, combined with his leadership role at dorsaVi, highlights his significant contributions to advancing motion analysis technologies. His active engagement in both professional and public discourse further underscores his commitment to innovation and industry leadership.
